See All Resources

Home > Resources > Guidelines > ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?

ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?

Go to Resource
Share:

Link is copied!

Get Certified

See All Certifications
A white doctor and a black doctor discuss the test results

Cardio-Oncology Knowledge

Go To Certification
A map of the world
Chapters

North America

Europe

Asia + Oceania

South America

Africa